Hypertension and dyslipidemia are two of the most commonly co-occurring cardiovascular
risk factors which together cause an increase in coronary heart disease-related events that …

OBJECTIVE To investigate the efficacy and safety of single-pill amlodipine/atorvastatin
therapy for the simultaneous treatment of hypertension (HTN) and dyslipidemia in African …

This review describes the clinical profile and rationale for the development of a single-pill
formulation of the calcium channel blocker amlodipine besylate, a blood pressure-lowering …

The present study was aimed to optimize capsulated unfolding type gastroretentive bilayer
film constituting immediate release (IR) layer of amlodipine besylate and sustained release …

Background: The fixed-dose combination containing the antihypertensive agent amlodipine
and the statin, atorvastatin, is the first combination of its kind designed to treat two risk factors …

This review describes the clinical profile and rationale for the development of a single-pill
formulation of the calcium channel blocker amlodipine besylate, a blood-pressure--lowering …

Данная статья представляет собой вторую часть обзора литературы по
использованию антагонистов кальция в лечении артериальной гипертензии …

The aim was to evaluate the efficacy of a single-pill combination of atorvastatin/amlodipine
in patients with arterial hypertension, dyslipidemia and moderate to high cardiovascular risk …

Cardiovascular disease is the leading cause of morbidity and mortality throughout the
developed world. Risk factors for cardiovascular disease commonly coexist, which multiplies …

Статья посвящена проблеме лечения больных артериальной гипертонией и
дислипидемией. Обсуждаются вопросы приверженности к лечению …